You can now read 10 articles a month for free. Read as much as you want anywhere and anytime for just 99¢.

Pfizer says it won't make offer for AstraZeneca

NEW YORK (AP) — Pfizer says it does not intend to make a takeover offer for British drugmaker AstraZeneca.

The announcement Monday comes a week after AstraZeneca’s board rejected a proposed $119 billion buyout offer from Pfizer, the world’s second-biggest drugmaker by revenue.

Continue reading below

Pfizer Chairman and CEO Ian Read says the company’s final proposal represented full value for AstraZeneca.

Pfizer, the maker of Lipitor and Viagra, has been courting No. 8 AstraZeneca since January, saying their businesses would be stronger together.

Pfizer had been waiting for AstraZeneca to engage in merger talks by a Monday deadline.

Pfizer has previously said it would not make a hostile takeover bid directly to AstraZeneca’s stockholders.

Loading comments...

You have reached the limit of 10 free articles in a month

Stay informed with unlimited access to Boston’s trusted news source.

  • High-quality journalism from the region’s largest newsroom
  • Convenient access across all of your devices
  • Today’s Headlines daily newsletter
  • Subscriber-only access to exclusive offers, events, contests, eBooks, and more
  • Less than 25¢ a week